Beximco Pharmaceuticals PLC. Share Price
Stocks
BXPHARMA
BD0453BXPH04
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Dhaka S.E.
02/11/2026
|
5-day change | 1st Jan Change | ||
| 142.10 BDT | -1.52% |
|
-2.67% | +39.18% |
| 29/10 | Beximco Pharmaceuticals plc announces Annual dividend | CI |
| 01/10 | Beximco Pharmaceuticals Reaches Settlement With Bangladeshi Regulator Over Board Restructuring | MT |
| Market Cap | 6.34TCr 51Cr 46Cr 42Cr 38Cr 72Cr 4.85TCr 73Cr 499.36Cr 201.54Cr 2.55TCr 191.79Cr 187.75Cr 8.08TCr | P/E 2026 |
6.97x | P/E 2027 * | 6.39x |
|---|---|---|---|---|---|
| Enterprise Value | 6.34TCr 51Cr 46Cr 42Cr 38Cr 72Cr 4.85TCr 73Cr 499.36Cr 201.54Cr 2.55TCr 191.79Cr 187.75Cr 8.08TCr | EV / Sales 2026 |
-
| EV / Sales 2027 * | 1.03x |
| Free-Float |
85.91% | Yield 2026 * |
4.24% | Yield 2027 * | 4.85% |
| 1 day | -1.52% | ||
| 1 week | -2.67% | ||
| Current month | -1.11% | ||
| 1 month | -3.46% | ||
| 3 months | -5.83% | ||
| 6 months | +23.78% | ||
| Current year | +39.18% |
| 1 week | 141.7 |  | 145.8 |
| 1 month | 138.5 | | 147.9 |
| Current year | 99.5 | | 158.5 |
| 1 year | 99.5 | | 158.5 |
| 3 years | 64.2 | | 158.5 |
| 5 years | 64.2 | | 234 |
| 10 years | 47.36 | | 255.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iqbal Ahmed
CEO | Chief Executive Officer | - | 04/03/2024 |
| Director of Finance/CFO | 63 | 01/01/2003 | |
Mohammad Haque
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 19/06/2009 | |
| Director/Board Member | - | 01/02/2010 | |
Iqbal Ahmed
BRD | Director/Board Member | - | 01/01/1985 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.52% | -2.67% | +21.66% | -2.80% | 52Cr | |
| -0.46% | +10.80% | +63.52% | +154.48% | 1,26300Cr | |
| -0.97% | +2.56% | +43.25% | +81.96% | 66TCr | |
| -2.05% | +1.12% | +32.47% | +102.74% | 52TCr | |
| -1.54% | +1.61% | +53.42% | +67.10% | 39TCr | |
| -0.78% | +2.13% | +72.55% | +44.25% | 37TCr | |
| -1.69% | +2.75% | +32.49% | +54.35% | 31TCr | |
| -0.72% | +8.08% | +11.15% | +34.09% | 29TCr | |
| -0.12% | +5.96% | +55.97% | +78.44% | 25TCr | |
| -0.21% | +9.16% | +42.19% | +112.41% | 21TCr | |
| Average | -0.76% | +5.26% | +42.87% | +72.70% | 42.62TCr | |
| Weighted average by Cap. | -0.65% | +6.60% | +49.14% | +97.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.48TCr 44Cr 39Cr 36Cr 33Cr 62Cr 4.19TCr 63Cr 431.54Cr 174.17Cr 2.21TCr 165.74Cr 162.25Cr 6.98TCr | 6.13TCr 49Cr 44Cr 40Cr 37Cr 69Cr 4.69TCr 71Cr 482.63Cr 194.79Cr 2.47TCr 185.36Cr 181.46Cr 7.81TCr |
| Net income | 866.2Cr 6.99Cr 6.24Cr 5.72Cr 5.21Cr 9.78Cr 662.8Cr 9.98Cr 68Cr 28Cr 349.1Cr 26Cr 26Cr 1.1TCr | 991.9Cr 8Cr 7.15Cr 6.55Cr 5.97Cr 11Cr 758.98Cr 11Cr 78Cr 32Cr 399.76Cr 30Cr 29Cr 1.26TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | BDT 142.10 | -1.52% | 3,86,700 |
| 01/26/01 | BDT 144.30 | +0.42% | 3,81,201 |
| 29/26/29 | BDT 143.70 | +0.49% | 4,73,934 |
| 28/26/28 | BDT 143.00 | +0.14% | 3,12,831 |
| 27/26/27 | BDT 142.80 | -1.24% | 7,00,170 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BXPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
